Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does antibiotic restriction prevent resistance?

J E McGowan1, D N Gerding

  • 1Emory University School of Medicine, Atlanta, GA, USA.

New Horizons (Baltimore, Md.)
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A US-based national surveillance study for the susceptibility and epidemiology of <i>Clostridioides difficile</i> isolates with special reference to ridinilazole: 2020-2021.

Antimicrobial agents and chemotherapy·2023
Same author

Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016.

Anaerobe·2020
Same author

U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016.

Antimicrobial agents and chemotherapy·2019
Same author

Correction for Cairns et al., "Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages".

Journal of clinical microbiology·2017
Same author

Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages.

Journal of clinical microbiology·2016
Same author

Fat Embolism.

Postgraduate medicine·2016
Same journal

Palliative care in the intensive care unit.

New horizons (Baltimore, Md.)·2001
Same journal

An international perspective on the treatment of pediatric shock: the Brazilian experience.

New horizons (Baltimore, Md.)·1998
Same journal

Nutrition and shock in pediatric patients.

New horizons (Baltimore, Md.)·1998
Same journal

Recent advances in pediatric cardiopulmonary resuscitation and advanced life support.

New horizons (Baltimore, Md.)·1998
Same journal

Potential protective role of the heat shock response in sepsis.

New horizons (Baltimore, Md.)·1998
Same journal

Molecular biology of septic shock.

New horizons (Baltimore, Md.)·1998
See all related articles

Antimicrobial resistance is a growing problem, and simply educating clinicians has not been effective. New strategies are urgently needed to control antimicrobial use and combat resistance.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Rising antimicrobial resistance in hospital organisms necessitates urgent action.
  • A causal link exists between antimicrobial agent use and resistance development.
  • Aminoglycoside use significantly impacts antimicrobial resistance rates.

Purpose of the Study:

  • To highlight the urgent need for effective antimicrobial use controls.
  • To emphasize the limitations of educational interventions in combating antimicrobial resistance.
  • To call for further research into antimicrobial stewardship strategies.

Main Methods:

  • Review of existing literature on antimicrobial resistance and usage.
  • Analysis of the ineffectiveness of educational interventions alone.

Related Experiment Videos

  • Identification of the need for large-scale controlled trials.

    • Main Results:

    • Educational efforts, even with quality management, have largely failed to curb antimicrobial resistance.
    • Antimicrobial usage directly influences resistance rates.
    • Current strategies are insufficient to manage the escalating problem.

    Conclusions:

    • Effective antimicrobial-use controls are essential to combat rising resistance.
    • Future research must focus on large-scale trials with robust methodologies.
    • Optimizing antimicrobial stewardship requires careful consideration of selection, dosage, and duration.